Sahyadri Clinical Research and Development Center
Pune, Maharashtra, India
Research institute in Pune, Maharashtra
33/34 B, Makarand Bhave Path, Karve Rd, Erandwane, Pune, Maharashtra 411004
About Sahyadri Clinical Research and Development Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
10
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
2
Onconova Therapeutics, Inc.
1
Clinical Trials at Sahyadri Clinical Research and Development Center
During the past decade, Sahyadri Clinical Research and Development Center conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 7 clinical trials were completed, i.e. on
average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy
2011-04-04
2014-03-28
Terminated
338
Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients
2011-03-01
2012-07-01
Completed
441
A Study Of PF-05280014 [Trastuzumab-Pfizer] Or Herceptin® [Trastuzumab-EU] Plus Paclitaxel In HER2 Positive First Line Metastatic Breast Cancer Treatment (REFLECTIONS B327-02)
2014-02-24
2020-06-27
Completed
707
Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA
2015-12-02
2021-07-26
Terminated
372
A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC
2017-04-27
2028-12-31
Active, not recruiting
296
A Study Of Two Inotuzumab Ozogamicin Doses in Relapsed/ Refractory Acute Lymphoblastic Leukemia Transplant Eligible Patients
2019-07-01
2023-09-13
Active, not recruiting
102
Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B
2020-03-09
2024-09-27
Recruiting
145
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Sahyadri Clinical Research and Development Center"
#1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator and "UCB Pharma" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Sahyadri Clinical Research and Development Center
According to Clinical.Site data, the most researched conditions in "Sahyadri Clinical Research and Development Center" are
"Hemophilia A" (2 trials), "Hemophilia B" (2 trials), "ACUTE LYMPHOBLASTIC LEUKEMIA" (1 trials), "Advanced Non-Small Cell Lung Cancer" (1 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "Sahyadri Clinical Research and Development Center" in a lesser frequency.
Clinical Trials Intervention Types at Sahyadri Clinical Research and Development Center
Most popular intervention types in "Sahyadri Clinical Research and Development Center" are "Drug" (11 trials) and "Biological" (3 trials). Other intervention types were less common.
The name of intervention was led by "Lorlatinib" (2 trials), "placebo" (2 trials), "pregabalin" (2 trials), "Any approved or standard-of-care therapy" (1 trials) and "Crizotinib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Sahyadri Clinical Research and Development Center
The vast majority of trials in "Sahyadri Clinical Research and Development Center" are
8 trials for "All" genders, 4 trials for "Male" genders and 1 trials for "Female" genders.
Clinical Trials Status at Sahyadri Clinical Research and Development Center
Currently, there are NaN active trials in "Sahyadri Clinical Research and Development Center".
undefined are not yet recruiting,
1 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Sahyadri Clinical Research and Development Center,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Sahyadri Clinical Research and Development Center, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 5 trials, and there were
also 0 trials that are defined as “Not Applicable".